FENNEC PHARMACEUTICALS INC.
FENC · XNASCIK 1211583fmd_0KS9GZ4HNT31X2675THAJ26TEAManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jul 01, 1996 to Sep 30, 2026, 80 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | – | 2 | 21 | 48 | 45 |
| Cost of revenue | – | – | – | – | – | – | 0 | 1 | – | – |
| Net interest income | – | – | – | – | – | – | 0 | 0 | – | – |
| Gross profit | – | – | – | – | – | – | 1 | 20 | – | – |
| Research and development | 0 | 2 | 5 | 6 | 5 | 5 | 4 | 0 | 0 | 0 |
| Selling, general and administrative | – | – | – | – | – | – | 21 | 33 | 41 | 47 |
| Total operating expenses | – | – | – | 13 | 18 | 17 | 24 | 34 | 45 | 51 |
| Operating income | (3) | (7) | (10) | (13) | (18) | (17) | (23) | (13) | 3 | (6) |
| Interest expense | – | – | – | – | – | – | – | 3 | 4 | 2 |
| Interest and investment income | – | – | – | – | – | – | – | 0 | 2 | 1 |
| Other non-operating income (expense) | 0 | (0) | 1 | 0 | (0) | (0) | (1) | (3) | (3) | (3) |
| Income before taxes | (3) | (7) | (10) | (13) | (18) | (17) | (24) | (16) | (0) | (10) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | 0 | 0 |
| Net income from continuing operations | (3) | (7) | (10) | (13) | (18) | (17) | (24) | – | (0) | (10) |
| Net income | (3) | (7) | (10) | (13) | (18) | (17) | (24) | (16) | (0) | (10) |